Back to Search
Start Over
Ad hoc afatinib in an eldery lung cancer patient with EGFR exon 19 deletion L747-A750>P
- Publication Year :
- 2022
-
Abstract
- Approximately 10–20% of patients with non–small-cell lung cancer (NSCLC) harbor an epidermal growth factor receptor (EGFR) [...]
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....e70acfccd1382d32da34a101f17f6ebe